Global Prils Market Research Report Forecast to 2023

Array
(
    [id] => 1673499
    [discount] => PDF-18-ENTERPRISE WIDE LICENCE-20------
    [isbn] => 
    [title] => Global Prils Market Research Report Forecast to 2023
    [upcommingtext] => 
    [seo_url] => global-prils-market-research-report-forecast
    [shortdesc] => 
    [meta_title] => Global Prils Market Research Report Forecast to 2023
    [keyword] => Global Prils Market Research Report Forecast to 2023
    [description] => Prils Market Information by Type (Ramipril, Quinapril, Cilazapril, & Benazepril), Application (Hypertension, Heart Failure, & Chronic Kidney Disorders), & Region (Americas, Europe, Asia-Pacific, & the Middle East & Africa) -
    [curr] => USD
    [category] => 1200
    [publisher] => 182
    [published_date] => 2019-06-30
    [country] => 230
    [author_name] => 
    [page_num] => 109
    [abstract] => Prils Market Information by Type (Ramipril, Quinapril, Cilazapril, & Benazepril), Application (Hypertension, Heart Failure, & Chronic Kidney Disorders), & Region (Americas, Europe, Asia-Pacific, & the Middle East & Africa) - Global Forecast till 2023
Market analysis

The global prils market incorporates active pharmaceutical ingredients (APIs) fixings. APIs are naturally dynamic fixings or substances which are significant the piece of any medication. There are distinctive APIs accessible with various properties, and they are utilized by pharmaceutical, biotech, and nourishing enterprises appropriately to grow new items. The key variables in charge of driving the market are expanding the commonness of heart illnesses, hypertension and kidney related issues, rising geriatric populace, developing the significance of nonexclusive medications, and furthermore the general take-up of the biopharmaceuticals business. Notwithstanding, factors, for example, negative medication cost-control arrangements in numerous nations, expanding infiltration of fake medications, and complex permit reestablishment systems hamper the market development. The global prils market is anticipated to grow at CAGR of 4.3% to reach the valuation of USD 2,591.5 million till the year 2023.

Market segmentation

The global prils market is segmented on the basis of its type, application, and regional demand. Based on its type, the global prils market is categorized into Quinapril, Ramipril, Benazepril, and Cilazapril. The global prils market is segmented on the basis of its application, is divided into heart failure, hypertension, chronic kidney disorders, and others.

Regional analysis

Geographically, the global prils market is divided into global regions like Europe, North America, Asia- Pacific, Middle East, LATAM, and Africa.

Major players

Sun Pharmaceutical Industries Ltd, Merck KGaA, Manus Aktteva Biopharma LLP, Canagen Pharmaceuticals Inc., Novartis AG, Aurobindo Pharma, Lupin, Pfizer, Inc., Mylan N.V., F. Hoffmann-La Roche, among others are some of the major players in the global prils market. [table_of_contents] =>

1 Executive Summary
2 Market Introduction
2.1 Scope of the Study
2.2 Research Objective
2.3 List of Assumptions
3 Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
4 Market Dynamics
4.1 Introduction
4.2 Drivers
4.2.1 Growing Pharmaceutical Industry
4.2.2 Growing Prevalence of Chronic Diseases Across the World
4.2.3 Growing Importance of Generic Drugs
4.3 Restraints
4.3.1 Stringent Regulatory Policies
4.3.2 Adverse Drug Price Control Policies Across Numerous Countries
4.4 Opportunity
4.4.1 Development of New Drugs
4.5 Product Pipeline Analysis
4.5.1 Introduction
4.5.2 NT-proBNP Selected Prevention of Cardiac Events in Diabetic Patients
4.5.3 Testing Ramipril to Prevent Memory Loss in People with Glioblastoma
4.5.4 Ramipril Treatment of Claudication
4.5.5 Bariatric Surgery and Pharmacokinetics of Ramipril
5 Market Factor Analysis
5.1 Value Chain Analysis
5.1.1 R&D and Designing
5.1.2 Manufacturing
5.1.3 Distribution & Sales
5.1.4 Marketing & Sales
5.1.5 Post-Sales Review
5.2 Porter’s Five Forces Model
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Buyers
5.2.3 Threat of New Entrants
5.2.5 Intense Rivalry
5.3 Specifications & Purity Requirements
5.4 Patent Analysis
5.4.1 Introduction
5.4.2 Patent Analysis for Benazepril
5.4.2.1 Process for Preparation of Benazepril
5.4.3 Patent Analysis for Cilazapril
5.4.3.1 Process for Preparation of Enantiomerically Pure Cilazapril
5.4.3.2 Process for the Preparation of Cilazapril
5.4.3.3 Process for the Preparation of an Intermediate of Cilazapril
5.4.4 Patent Analysis of Quinapril
5.4.4.1 Methods for the Preparation of Quinapril
5.4.4.2 Methods for the Preparation of Quinapril Hydrochloride
5.4.4.3 Process for the Preparation of Highly Pure Crystalline Quinapril Hydrochloride
5.4.4.4 Formulations of Quinapril and Related Ace Inhibitors
5.4.5 Patent Analysis for Ramipril
5.4.5.1 Formulations of Ramipril
5.4.5.2 Stabilized Individually Coated Ramipril Particles, Compositions, and Methods
5.4.5.3 Use of Ramipril in the Prevention of Congestive Heart Failure
5.5 Regulatory Analysis
5.6 Pricing Evolution
6 Global Prils Market, by Type
6.1 Introduction
6.2 Ramipril
6.3 Quinapril
6.4 Cilazapril
6.5 Benazepril
7 Global Prils Market, by Application
7.1 Introduction
7.2 Hypertension
7.3 Heart Failure
7.4 Chronic Kidney Disorders
8 Global Prils Market, by Region
8.1 Introduction
8.2 Americas
8.2.1 North America
8.2.1.1 US
8.2.1.2 Canada
8.2.2 South America
8.3 Europe
8.3.1 Western Europe
8.3.1.1 Germany
8.3.1.2 UK
8.3.1.3 France
8.3.1.4 Italy
8.3.1.5 Spain
8.3.1.6 Rest of Western Europe
8.3.1.7 Eastern Europe
8.4 Asia-Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia-Pacific
8.5 Middle East & Africa
8.5.1 Middle East
8.5.2 Africa
9 Competitive landscape
9.1 Introduction
9.2 Key developments
10 Company Profiles
10.1 Aurobindo Pharma
10.1.1 Company Overview
10.1.2 Financial Overview
10.1.3 Products/Services Offered
10.1.4 Key Developments
10.1.5 SWOT Analysis
10.1.6 Key Strategies
10.2 Lupin
10.2.1 Company Overview
10.2.2 Financial Overview
10.2.3 Products/Services Offered
10.2.4 Key Developments
10.2.5 SWOT Analysis
10.2.6 Key Strategies
10.3 Pfizer, Inc.
10.3.1 Company Overview
10.3.2 Financial Overview
10.3.3 Products/Services Offered
10.3.4 Key Developments
10.3.5 SWOT Analysis
10.3.6 Key Strategies
10.4 Mylan N.V.
10.4.1 Company Overview
10.4.2 Financial Overview
10.4.3 Products/Services Offered
10.4.4 Key Developments
10.4.5 SWOT Analysis
10.4.6 Key Strategies
10.5 F. Hoffmann-La Roche
10.5.1 Company Overview
10.5.2 Financial Overview
10.5.3 Products/Services Offered
10.5.4 Key Developments
10.5.5 SWOT Analysis
10.5.6 Key Strategies
10.6 Sun Pharmaceutical Industries Ltd
10.6.1 Company Overview
10.6.2 Financial Overview
10.6.3 Products/Services Offered
10.6.4 Key Developments
10.6.5 SWOT Analysis
10.6.6 Key Strategies
10.7 Merck KGaA
10.7.1 Company Overview
10.7.2 Financial Overview
10.7.3 Products/Services Offered
10.7.4 Key Developments
10.7.5 SWOT Analysis
10.7.6 Key Strategies
10.8 Manus Aktteva Biopharma LLP
10.8.1 Company Overview
10.8.2 Financial Overview
10.8.3 Products/Services Offered
10.8.4 Key Developments
10.8.5 SWOT Analysis
10.8.6 Key Strategies
10.9 Canagen Pharmaceuticals Inc.
10.9.1 Company Overview
10.9.2 Financial Overview
10.9.3 Products/Services Offered
10.9.4 Key Developments
10.9.5 SWOT Analysis
10.9.6 Key Strategies
10.1 Novartis AG
10.10.1 Company Overview
10.10.2 Financial Overview
10.10.3 Products/Services Offered
10.10.4 Key Developments
10.10.5 SWOT Analysis
10.10.6 Key Strategies
11 Appendix
References
Related Reports [list_of_tables] =>

TABLE 1 LIST OF ASSUMPTIONS
TABLE 2 PRIMARY INTERVIEWS
TABLE 3 PRILS MARKET: PRODUCT PIPELINE ANALYSIS
TABLE 4 PORTER’S FIVE FORCES ANALYSIS: GLOBAL PRILS MARKET
TABLE 5 PATENT ANALYSIS FOR BENAZEPRIL
TABLE 6 PATENT ANALYSIS FOR CILAZAPRIL
TABLE 7 PATENT ANALYSIS FOR QUINAPRIL
TABLE 8 PATENT ANALYSIS FOR RAMIPRIL
TABLE 9 AMERICAS: AVERAGE SELLING PRICE (ASP), BY TYPE, (USD/KG) 2018
TABLE 10 EUROPE: AVERAGE SELLING PRICE (ASP) ,BY TYPE, (USD/KG) 2018
TABLE 11 ASIA-PACIFIC: AVERAGE SELLING PRICE (ASP), BY TYPE, (USD/KG) 2018
TABLE 12 MIDDLE EAST: AVERAGE SELLING PRICE (ASP), BY TYPE, (USD/KG) 2018
TABLE 13 GLOBAL PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 14 GLOBAL PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
TABLE 15 GLOBAL PRILS MARKET, FOR RAMIPRIL, BY REGION, 2015 TO 2023 (USD MILLION)
TABLE 16 GLOBAL PRILS MARKET, FOR QUINAPRIL, BY REGION, 2015 TO 2023 (USD MILLION)
TABLE 17 GLOBAL PRILS MARKET, FOR CILAZAPRIL, BY REGION, 2015 TO 2023 (USD MILLION)
TABLE 18 GLOBAL PRILS MARKET, FOR BENAZEPRIL, BY REGION, 2015 TO 2023 (USD MILLION)
TABLE 19 GLOBAL PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
TABLE 20 GLOBAL PRILS MARKET, FOR HYPERTENSION, BY REGION, 2015 TO 2023 (USD MILLION)
TABLE 21 GLOBAL PRILS MARKET, FOR HEART FAILURE, BY REGION, 2015 TO 2023 (USD MILLION)
TABLE 22 GLOBAL PRILS MARKET, FOR CHRONIC KIDNEY DISORDERS, BY REGION, 2015 TO 2023 (USD MILLION)
TABLE 23 GLOBAL PRILS MARKET, BY REGION, 2015 TO 2023 (USD MILLION)
TABLE 24 AMERICAS: PRILS MARKET, BY REGION, 2015 TO 2023 (USD MILLION)
TABLE 25 AMERICAS: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 26 AMERICAS: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
TABLE 27 AMERICAS: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
TABLE 28 NORTH AMERICA: PRILS MARKET, BY REGION, 2015 TO 2023 (USD MILLION)
TABLE 29 NORTH AMERICA: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 30 NORTH AMERICA: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
TABLE 31 NORTH AMERICA: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
TABLE 32 US: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 33 US: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
TABLE 34 US: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
TABLE 35 CANADA: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 36 CANADA: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
TABLE 37 CANADA: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
TABLE 38 SOUTH AMERICA: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 39 SOUTH AMERICA: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
TABLE 40 SOUTH AMERICA: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
TABLE 41 EUROPE: PRILS MARKET, BY REGION, 2015 TO 2023 (USD MILLION)
TABLE 42 EUROPE: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 43 EUROPE: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
TABLE 44 EUROPE: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
TABLE 45 WESTERN EUROPE: PRILS MARKET, BY REGION, 2015 TO 2023 (USD MILLION)
TABLE 46 WESTERN EUROPE: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 47 WESTERN EUROPE: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
TABLE 48 WESTERN EUROPE: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
TABLE 49 GERMANY: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 50 GERMANY: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
TABLE 51 GERMANY: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
TABLE 52 UK: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 53 UK: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
TABLE 54 UK: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
TABLE 55 FRANCE: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 56 FRANCE: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
TABLE 57 FRANCE: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
TABLE 58 ITALY: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 59 ITALY: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
TABLE 60 ITALY: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
TABLE 61 SPAIN: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 62 SPAIN: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
TABLE 63 SPAIN: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
TABLE 64 REST OF WESTERN EUROPE: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 65 REST OF WESTERN EUROPE: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
TABLE 66 REST OF WESTERN EUROPE: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
TABLE 67 EASTERN EUROPE: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 68 EASTERN EUROPE: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
TABLE 69 EASTERN EUROPE: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
TABLE 70 ASIA-PACIFIC: PRILS MARKET, BY REGION, 2015 TO 2023 (USD MILLION)
TABLE 71 ASIA-PACIFIC: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 72 ASIA-PACIFIC: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
TABLE 73 ASIA-PACIFIC: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
TABLE 74 JAPAN: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 75 JAPAN: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
TABLE 76 JAPAN: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
TABLE 77 CHINA: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 78 CHINA: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
TABLE 79 CHINA: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
TABLE 80 INDIA: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 81 INDIA: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
TABLE 82 INDIA: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
TABLE 83 AUSTRALIA: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 84 AUSTRALIA: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
TABLE 85 AUSTRALIA: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
TABLE 86 SOUTH KOREA: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 87 SOUTH KOREA: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
TABLE 88 SOUTH KOREA: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
TABLE 89 REST OF ASIA-PACIFIC: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 90 REST OF ASIA-PACIFIC: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
TABLE 91 REST OF ASIA-PACIFIC: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
TABLE 92 MIDDLE EAST & AFRICA: PRILS MARKET, BY REGION, 2015 TO 2023 (USD MILLION)
TABLE 93 MIDDLE EAST & AFRICA: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 94 MIDDLE EAST & AFRICA: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
TABLE 95 MIDDLE EAST & AFRICA: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
TABLE 96 MIDDLE EAST: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 97 MIDDLE EAST: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
TABLE 98 MIDDLE EAST: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
TABLE 99 AFRICA: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 100 AFRICA: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
TABLE 101 AFRICA: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
TABLE 102 MAJOR MANUFACTURERS IN THE GLOBAL PRILS MARKETMARKET
TABLE 103 KEY DEVELOPMENTS BY PLAYERS IN THE MARKET [list_of_figures] =>

FIGURE 1 MARKET SYNOPSIS
FIGURE 2 GLOBAL PRILS MARKET: STRUCTURE
FIGURE 3 RESEARCH PROCESS
FIGURE 4 TOP-DOWN AND BOTTOM-UP APPROACHES
FIGURE 5 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL PRILS MARKET
FIGURE 6 VALUE CHAIN: GLOBAL PRILS MARKET
FIGURE 7 GLOBAL PRILS MARKET, BY TYPE, 2017 & 2023 (USD MILLION)
FIGURE 8 GLOBAL PRILS MARKET, BY APPLICATION, 2017 & 2023 (USD MILLION)
FIGURE 9 GLOBAL PRILS MARKET SHARE, BY REGION, 2017 (%)
FIGURE 10 AMERICAS: PRILS MARKET SHARE, BY REGION, 2017 (%)
FIGURE 11 NORTH AMERICA: PRILS MARKET SHARE, BY REGION, 2017 (%)
FIGURE 12 EUROPE: PRILS MARKET SHARE, BY REGION, 2017 (%)
FIGURE 13 WESTERN EUROPE: PRILS MARKET SHARE, BY REGION, 2017 (%)
FIGURE 14 ASIA-PACIFIC: PRILS MARKET SHARE, BY REGION, 2017 (%)
FIGURE 15 MIDDLE EAST & AFRICA: PRILS MARKET SHARE, BY REGION, 2017 (%)
FIGURE 16 CATEGORY WISE SHARE OF KEY DEVELOPMENTS [sample_page] => [brochure] => [new_price] => PDF-4450-ENTERPRISE WIDE LICENCE-6250-SITE LICENCE--ENTERPRISE WIDE LICENCE--Enterprise Wide Licence--Enterprise Wide Licence--Multi User Licence- )
discount aarkstore
Prils Market Information by Type (Ramipril, Quinapril, Cilazapril, & Benazepril), Application (Hypertension, Heart Failure, & Chronic Kidney Disorders), & Region (Americas, Europe, Asia-Pacific, & the Middle East & Africa) - Global Forecast till 2023
Market analysis

The global prils market incorporates active pharmaceutical ingredients (APIs) fixings. APIs are naturally dynamic fixings or substances which are significant the piece of any medication. There are distinctive APIs accessible with various properties, and they are utilized by pharmaceutical, biotech, and nourishing enterprises appropriately to grow new items. The key variables in charge of driving the market are expanding the commonness of heart illnesses, hypertension and kidney related issues, rising geriatric populace, developing the significance of nonexclusive medications, and furthermore the general take-up of the biopharmaceuticals business. Notwithstanding, factors, for example, negative medication cost-control arrangements in numerous nations, expanding infiltration of fake medications, and complex permit reestablishment systems hamper the market development. The global prils market is anticipated to grow at CAGR of 4.3% to reach the valuation of USD 2,591.5 million till the year 2023.

Market segmentation

The global prils market is segmented on the basis of its type, application, and regional demand. Based on its type, the global prils market is categorized into Quinapril, Ramipril, Benazepril, and Cilazapril. The global prils market is segmented on the basis of its application, is divided into heart failure, hypertension, chronic kidney disorders, and others.

Regional analysis

Geographically, the global prils market is divided into global regions like Europe, North America, Asia- Pacific, Middle East, LATAM, and Africa.

Major players

Sun Pharmaceutical Industries Ltd, Merck KGaA, Manus Aktteva Biopharma LLP, Canagen Pharmaceuticals Inc., Novartis AG, Aurobindo Pharma, Lupin, Pfizer, Inc., Mylan N.V., F. Hoffmann-La Roche, among others are some of the major players in the global prils market.


1Executive Summary
2Market Introduction
2.1Scope of the Study
2.2Research Objective
2.3List of Assumptions
3Research Methodology
3.1Research Process
3.2Primary Research
3.3Secondary Research
3.4Market Size Estimation
4Market Dynamics
4.1Introduction
4.2Drivers
4.2.1Growing Pharmaceutical Industry
4.2.2Growing Prevalence of Chronic Diseases Across the World
4.2.3Growing Importance of Generic Drugs
4.3Restraints
4.3.1Stringent Regulatory Policies
4.3.2Adverse Drug Price Control Policies Across Numerous Countries
4.4Opportunity
4.4.1Development of New Drugs
4.5Product Pipeline Analysis
4.5.1Introduction
4.5.2NT-proBNP Selected Prevention of Cardiac Events in Diabetic Patients
4.5.3Testing Ramipril to Prevent Memory Loss in People with Glioblastoma
4.5.4Ramipril Treatment of Claudication
4.5.5Bariatric Surgery and Pharmacokinetics of Ramipril
5Market Factor Analysis
5.1Value Chain Analysis
5.1.1R&D and Designing
5.1.2Manufacturing
5.1.3Distribution & Sales
5.1.4Marketing & Sales
5.1.5Post-Sales Review
5.2Porters Five Forces Model
5.2.1Bargaining Power of Suppliers
5.2.2Bargaining Power of Buyers
5.2.3Threat of New Entrants
5.2.5Intense Rivalry
5.3Specifications & Purity Requirements
5.4Patent Analysis
5.4.1Introduction
5.4.2Patent Analysis for Benazepril
5.4.2.1Process for Preparation of Benazepril
5.4.3Patent Analysis for Cilazapril
5.4.3.1Process for Preparation of Enantiomerically Pure Cilazapril
5.4.3.2Process for the Preparation of Cilazapril
5.4.3.3Process for the Preparation of an Intermediate of Cilazapril
5.4.4Patent Analysis of Quinapril
5.4.4.1Methods for the Preparation of Quinapril
5.4.4.2Methods for the Preparation of Quinapril Hydrochloride
5.4.4.3Process for the Preparation of Highly Pure Crystalline Quinapril Hydrochloride
5.4.4.4Formulations of Quinapril and Related Ace Inhibitors
5.4.5Patent Analysis for Ramipril
5.4.5.1Formulations of Ramipril
5.4.5.2Stabilized Individually Coated Ramipril Particles, Compositions, and Methods
5.4.5.3Use of Ramipril in the Prevention of Congestive Heart Failure
5.5Regulatory Analysis
5.6Pricing Evolution
6Global Prils Market, by Type
6.1Introduction
6.2Ramipril
6.3Quinapril
6.4Cilazapril
6.5Benazepril
7Global Prils Market, by Application
7.1Introduction
7.2Hypertension
7.3Heart Failure
7.4Chronic Kidney Disorders
8Global Prils Market, by Region
8.1Introduction
8.2Americas
8.2.1North America
8.2.1.1US
8.2.1.2Canada
8.2.2South America
8.3Europe
8.3.1Western Europe
8.3.1.1Germany
8.3.1.2UK
8.3.1.3France
8.3.1.4Italy
8.3.1.5Spain
8.3.1.6Rest of Western Europe
8.3.1.7Eastern Europe
8.4Asia-Pacific
8.4.1Japan
8.4.2China
8.4.3India
8.4.4Australia
8.4.5South Korea
8.4.6Rest of Asia-Pacific
8.5Middle East & Africa
8.5.1Middle East
8.5.2Africa
9Competitive landscape
9.1Introduction
9.2Key developments
10Company Profiles
10.1Aurobindo Pharma
10.1.1Company Overview
10.1.2Financial Overview
10.1.3Products/Services Offered
10.1.4Key Developments
10.1.5SWOT Analysis
10.1.6Key Strategies
10.2Lupin
10.2.1Company Overview
10.2.2Financial Overview
10.2.3Products/Services Offered
10.2.4Key Developments
10.2.5SWOT Analysis
10.2.6Key Strategies
10.3Pfizer, Inc.
10.3.1Company Overview
10.3.2Financial Overview
10.3.3Products/Services Offered
10.3.4Key Developments
10.3.5SWOT Analysis
10.3.6Key Strategies
10.4Mylan N.V.
10.4.1Company Overview
10.4.2Financial Overview
10.4.3Products/Services Offered
10.4.4Key Developments
10.4.5SWOT Analysis
10.4.6Key Strategies
10.5F. Hoffmann-La Roche
10.5.1Company Overview
10.5.2Financial Overview
10.5.3Products/Services Offered
10.5.4Key Developments
10.5.5SWOT Analysis
10.5.6Key Strategies
10.6Sun Pharmaceutical Industries Ltd
10.6.1Company Overview
10.6.2Financial Overview
10.6.3Products/Services Offered
10.6.4Key Developments
10.6.5SWOT Analysis
10.6.6Key Strategies
10.7Merck KGaA
10.7.1Company Overview
10.7.2Financial Overview
10.7.3Products/Services Offered
10.7.4Key Developments
10.7.5SWOT Analysis
10.7.6Key Strategies
10.8Manus Aktteva Biopharma LLP
10.8.1Company Overview
10.8.2Financial Overview
10.8.3Products/Services Offered
10.8.4Key Developments
10.8.5SWOT Analysis
10.8.6Key Strategies
10.9Canagen Pharmaceuticals Inc.
10.9.1Company Overview
10.9.2Financial Overview
10.9.3Products/Services Offered
10.9.4Key Developments
10.9.5SWOT Analysis
10.9.6Key Strategies
10.1Novartis AG
10.10.1Company Overview
10.10.2Financial Overview
10.10.3Products/Services Offered
10.10.4Key Developments
10.10.5SWOT Analysis
10.10.6Key Strategies
11Appendix
References
Related Reports

List Of Tables



TABLE 1LIST OF ASSUMPTIONS
TABLE 2PRIMARY INTERVIEWS
TABLE 3PRILS MARKET: PRODUCT PIPELINE ANALYSIS
TABLE 4PORTERS FIVE FORCES ANALYSIS: GLOBAL PRILS MARKET
TABLE 5PATENT ANALYSIS FOR BENAZEPRIL
TABLE 6PATENT ANALYSIS FOR CILAZAPRIL
TABLE 7PATENT ANALYSIS FOR QUINAPRIL
TABLE 8PATENT ANALYSIS FOR RAMIPRIL
TABLE 9AMERICAS: AVERAGE SELLING PRICE (ASP), BY TYPE, (USD/KG) 2018
TABLE 10EUROPE: AVERAGE SELLING PRICE (ASP) ,BY TYPE, (USD/KG) 2018
TABLE 11ASIA-PACIFIC: AVERAGE SELLING PRICE (ASP), BY TYPE, (USD/KG) 2018
TABLE 12MIDDLE EAST: AVERAGE SELLING PRICE (ASP), BY TYPE, (USD/KG) 2018
TABLE 13GLOBAL PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 14GLOBAL PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
TABLE 15GLOBAL PRILS MARKET, FOR RAMIPRIL, BY REGION, 2015 TO 2023 (USD MILLION)
TABLE 16GLOBAL PRILS MARKET, FOR QUINAPRIL, BY REGION, 2015 TO 2023 (USD MILLION)
TABLE 17GLOBAL PRILS MARKET, FOR CILAZAPRIL, BY REGION, 2015 TO 2023 (USD MILLION)
TABLE 18GLOBAL PRILS MARKET, FOR BENAZEPRIL, BY REGION, 2015 TO 2023 (USD MILLION)
TABLE 19GLOBAL PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
TABLE 20GLOBAL PRILS MARKET, FOR HYPERTENSION, BY REGION, 2015 TO 2023 (USD MILLION)
TABLE 21GLOBAL PRILS MARKET, FOR HEART FAILURE, BY REGION, 2015 TO 2023 (USD MILLION)
TABLE 22GLOBAL PRILS MARKET, FOR CHRONIC KIDNEY DISORDERS, BY REGION, 2015 TO 2023 (USD MILLION)
TABLE 23GLOBAL PRILS MARKET, BY REGION, 2015 TO 2023 (USD MILLION)
TABLE 24AMERICAS: PRILS MARKET, BY REGION, 2015 TO 2023 (USD MILLION)
TABLE 25AMERICAS: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 26AMERICAS: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
TABLE 27AMERICAS: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
TABLE 28NORTH AMERICA: PRILS MARKET, BY REGION, 2015 TO 2023 (USD MILLION)
TABLE 29NORTH AMERICA: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 30NORTH AMERICA: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
TABLE 31NORTH AMERICA: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
TABLE 32US: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 33US: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
TABLE 34US: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
TABLE 35CANADA: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 36CANADA: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
TABLE 37CANADA: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
TABLE 38SOUTH AMERICA: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 39SOUTH AMERICA: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
TABLE 40SOUTH AMERICA: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
TABLE 41EUROPE: PRILS MARKET, BY REGION, 2015 TO 2023 (USD MILLION)
TABLE 42EUROPE: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 43EUROPE: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
TABLE 44EUROPE: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
TABLE 45WESTERN EUROPE: PRILS MARKET, BY REGION, 2015 TO 2023 (USD MILLION)
TABLE 46WESTERN EUROPE: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 47WESTERN EUROPE: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
TABLE 48WESTERN EUROPE: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
TABLE 49GERMANY: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 50GERMANY: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
TABLE 51GERMANY: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
TABLE 52UK: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 53UK: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
TABLE 54UK: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
TABLE 55FRANCE: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 56FRANCE: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
TABLE 57FRANCE: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
TABLE 58ITALY: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 59ITALY: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
TABLE 60ITALY: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
TABLE 61SPAIN: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 62SPAIN: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
TABLE 63SPAIN: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
TABLE 64REST OF WESTERN EUROPE: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 65REST OF WESTERN EUROPE: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
TABLE 66REST OF WESTERN EUROPE: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
TABLE 67EASTERN EUROPE: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 68EASTERN EUROPE: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
TABLE 69EASTERN EUROPE: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
TABLE 70ASIA-PACIFIC: PRILS MARKET, BY REGION, 2015 TO 2023 (USD MILLION)
TABLE 71ASIA-PACIFIC: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 72ASIA-PACIFIC: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
TABLE 73ASIA-PACIFIC: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
TABLE 74JAPAN: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 75JAPAN: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
TABLE 76JAPAN: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
TABLE 77CHINA: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 78CHINA: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
TABLE 79CHINA: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
TABLE 80INDIA: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 81INDIA: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
TABLE 82INDIA: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
TABLE 83AUSTRALIA: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 84AUSTRALIA: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
TABLE 85AUSTRALIA: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
TABLE 86SOUTH KOREA: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 87SOUTH KOREA: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
TABLE 88SOUTH KOREA: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
TABLE 89REST OF ASIA-PACIFIC: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 90REST OF ASIA-PACIFIC: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
TABLE 91REST OF ASIA-PACIFIC: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
TABLE 92MIDDLE EAST & AFRICA: PRILS MARKET, BY REGION, 2015 TO 2023 (USD MILLION)
TABLE 93MIDDLE EAST & AFRICA: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 94MIDDLE EAST & AFRICA: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
TABLE 95MIDDLE EAST & AFRICA: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
TABLE 96MIDDLE EAST: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 97MIDDLE EAST: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
TABLE 98MIDDLE EAST: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
TABLE 99AFRICA: PRILS MARKET, BY TYPE, 2015 TO 2023 (USD MILLION)
TABLE 100AFRICA: PRILS MARKET, BY TYPE, 2015 TO 2023 (VOLUME KG)
TABLE 101AFRICA: PRILS MARKET, BY APPLICATION, 2015 TO 2023 (USD MILLION)
TABLE 102MAJOR MANUFACTURERS IN THE GLOBAL PRILS MARKETMARKET
TABLE 103KEY DEVELOPMENTS BY PLAYERS IN THE MARKET

List Of Figures



FIGURE 1MARKET SYNOPSIS
FIGURE 2GLOBAL PRILS MARKET: STRUCTURE
FIGURE 3RESEARCH PROCESS
FIGURE 4TOP-DOWN AND BOTTOM-UP APPROACHES
FIGURE 5MARKET DYNAMICS: ANALYSIS OF THE GLOBAL PRILS MARKET
FIGURE 6VALUE CHAIN: GLOBAL PRILS MARKET
FIGURE 7GLOBAL PRILS MARKET, BY TYPE, 2017 & 2023 (USD MILLION)
FIGURE 8GLOBAL PRILS MARKET, BY APPLICATION, 2017 & 2023 (USD MILLION)
FIGURE 9GLOBAL PRILS MARKET SHARE, BY REGION, 2017 (%)
FIGURE 10AMERICAS: PRILS MARKET SHARE, BY REGION, 2017 (%)
FIGURE 11NORTH AMERICA: PRILS MARKET SHARE, BY REGION, 2017 (%)
FIGURE 12EUROPE: PRILS MARKET SHARE, BY REGION, 2017 (%)
FIGURE 13WESTERN EUROPE: PRILS MARKET SHARE, BY REGION, 2017 (%)
FIGURE 14ASIA-PACIFIC: PRILS MARKET SHARE, BY REGION, 2017 (%)
FIGURE 15MIDDLE EAST & AFRICA: PRILS MARKET SHARE, BY REGION, 2017 (%)
FIGURE 16CATEGORY WISE SHARE OF KEY DEVELOPMENTS

Global Patient Circuit Market By Type (Open, Closed, Semi-Closed), By Use (Single Use v/s Reusable), By Application (Anesthesia, Respiratory Dysfunction, Others), By End User (Hospitals, Ambulatory Centers, Others), By Region, Competition, Forecast & Opportunities, 2025

Global Patient Circuit Market By Type (Open, Closed, Semi-Closed), By Use (Single Use v/s Reusable), By Application (Anesthesia, Respiratory Dysfunction, Others), By End User (Hospitals, Ambulatory Centers, Others), By Region, Competition, Forecast & Opportunities, 2025 market research report available in single user pdf license with Aarkstore Enterprise at USD 4450

USD 4450 View Report

2024 Global Hematology and Flow Cytometry Markets: Supplier Shares by Country, Innovative Technologies and Strategic Profiles of Leading Competitors

This 42-page report provides detailed analyses of current and emerging hematology and flow cytometry technologies, and their potential market applications, including IT and robotics, lasers, monoclonal antibodies, molecular diagnostics, microdrop

USD 3500 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available